En Es
Categories

DxGen Corp.

DxGenco is Point-Of-Care (POC) IVD company focused on developing multi-markers for people with diabetes and tuberculosis. It provides total solutions for POC diagnostics and offers full service for developing POC products from concept through commercialization.
Gold member
Products Covid-19Summary
Close

Covid-19 DxGen Corp.

Clinical Laboratory

COVID-19 IgM/IgG Test
Epithod 616 COVID-19 IgM/IgG Test Kit

The Epithod 616 COVID-19 IgM/IgG Test Kit is intended for the semi-quantitative detection of IgM and IgG antibodies to SARS-CoV-2 in whole blood, serum, and plasma from humans with a fast test time of less than two minutes. The gold nanoparticle-based immunoassay test kit is designed for use on the Epithod 616 analyzer which ensures better accuracy and improved sensitivity in analyzing results, and eliminates the risk of undesirable misreading.
More details
Close

About DxGen Corp.

DxGenco is Point-Of-Care (POC) IVD company focused on developing multi-markers for people with diabetes and tuberculosis. It provides total solutions for POC diagnostics and offers full service for developing POC products from concept through commercialization.
FaceBook Twitter Google+ Linked in
Rapid Test Reader

Rapid Test Reader

Model: Ep.616-R
Request Information

Description:

The Ep.616-R analyzer provides lab quality immunoassay results by fluorescence or imaging photometry and is customizable for various rapid test kits. Portable and user-friendly, the rapid test reader allows healthcare professionals to derive quantitative or qualitative results within minutes.


Send A Message To This Supplier

* Required Information
* Email
To
DxGen Corp. (Rapid Test Reader)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions